Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hypothalamus-pituitary-ovarian axis (HPO axis)
- Target
- HPO axis
- Molecular classification
- Other (neuroendocrine system; not a protein, receptor, gene, or enzyme)
01
Overview
The hypothalamus-pituitary-ovarian axis (HPO axis) is a tightly regulated physiological system that coordinates menstrual cycle and female reproductive function via hormone signaling between the hypothalamus, pituitary gland, and ovaries. The hypothalamus secretes gonadotropin-releasing hormone (GnRH), stimulating the pituitary to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which then act on the ovaries to regulate production of estrogen and progesterone. This communication occurs in feedback loops, controlling follicle development, ovulation, and endometrial changes. Dysfunction or disease affecting any portion of the axis can lead to ovulatory disorders, infertility, or other health outcomes. The axis itself is the focus of various therapies aimed at restoring or modulating reproductive hormone states.
- Other names
- HPO axishypothalamic-pituitary-ovarian axishypothalamic-pituitary-gonadal axis (in female context)
02
Mechanism of action
Modulation of neuronal or endocrine signaling (e.g., stimulating or inhibiting GnRH, LH, FSH) Disruption or enhancement of feedback loops controlling sex steroids and ovulation
03
Biological functions
Regulation of reproductive hormone secretionMenstrual cycle controlOvulation control and oocyte maturationFeedback signaling between ovaries and brainRegulation of puberty, fertility, and menopause
04
Disease associations
Infertility (due to ovulatory disorders or axis dysfunction)Polycystic ovarian syndrome (PCOS)Primary ovarian insufficiency/premature ovarian failureHypogonadotropic hypogonadismEndocrinopathies affecting menstrual cycles
05
Safety considerations
Hormonal imbalance (e.g., ovarian hyperstimulation, suppression of axis, risk of multiple pregnancies)Disruption of feedback loops (potential impacts on bone health, cardiovascular risk, psychological well-being)
06
Interacting drugs
Gonadotropin-releasing hormone (GnRH) agonists and antagonists (modulate axis function)
4 more in the full profile.
07
Biomarkers
Serum LH, FSH, estradiol, progesterone levelsAnti-Müllerian hormone (AMH, ovarian reserve)
Beyond the preview
Go deeper on Hypothalamus-pituitary-ovarian axis (HPO axis).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hypothalamus-pituitary-ovarian axis (HPO axis).